CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Naltrexonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00326807
NCT00326807N/ACompleted
CompareCT.gov

A Randomized, Double-Blind, Placebo-Controlled Trial of Naltrexone in the Treatment of Concurrent Alcohol Dependence and Pathological Gambling

Centre for Addiction and Mental Health·interventional·Posted May 17, 2006·Updated May 17, 2006

In Brief

A clinical study evaluating Naltrexone for Concurrent Alcohol Dependence and Pathological Gambling. Completed, across 2 sites in 2 countries.

Detailed Summary

This study assessed whether naltrexone, an opioid antagonist, might be effective in reducing excessive gambling behavior in people who also drink heavily. The efficacy of naltrexone was evaluated in a randomized, double-blind, placebo-controlled trial. Fifty-two subjects who had significant problems with both gambling and alcohol received 11 weeks of either naltrexone or placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConcurrent Alcohol Dependence and Pathological Gambling
CountriesCanada, Finland
Collaborators--

Timeline

N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 17, 2006
Enrollment StartJun 1, 2001
Study CompletionJun 1, 2004
TodayJul 2, 2026
Posted 20.1 years ago

Interventions

Naltrexonedrug